Follow up of High Myopic Eyes
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: no drugs used for this study.
- Who it may be relevant to
- Registry conditions: Pathologic Myopia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Long Term Follow-up of Eyes With High Myopia
Overview
In this non-interventional retrospective and prospective observational study, the long-term evolution of clinical and iconographic characteristics of patients with pathological myopia will be considered Changes of some specific clinical, tomographic and angiographic variables evaluated on the baseline and after a minimum of 5 years follow-up will be studied.
Interventions
- Diagnostic test no drugs used for this study
tomographic, angiographic and clinical follow up
Primary outcome measures
- Proportion of subjects with neovascularization at follow-up visit [Time frame: at 5 years of follow up]
Eligibility criteria
Inclusion criteria
\- high myopia
Exclusion criteria
- acute ischemic optic neuropathy
- macular and peripapillary atrophy
- other forms of maculopathy
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Italy · 1 center
- Istituto Auxologico Italiano IRCCS — Milan
Identifiers
NCT: NCT06322433 · 37C301